Sanofi

A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wed, 02/20/13 - 11:46 am
multiple sclerosis
MS
Elan
Biogen Idec
Tysabri
Teva
XenoPort
Sanofi
BG-12
Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Yahoo
Tue, 02/19/13 - 09:54 am
lixisenatide
Sanofi
FDA
diabetes
GLP-1 receptor
Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Mon, 02/18/13 - 11:57 am
M&A
Biomarin
Sanofi
Genzyme
Sanofi's Orphan Drug Eliglustat Tartrate Successful in 2 Late-Stage Trials
Motley Fool
Sat, 02/16/13 - 11:55 am
Sanofi
orphan drugs
eliglustat tartrate
Gaucher disease
The Best Dividend in Big Pharma
Motley Fool
Thu, 02/14/13 - 10:06 am
Sanofi
dividends
Pfizer to Novartis Seen Gaining as Drought Ends: Health
Bloomberg
Thu, 02/14/13 - 10:05 am
Pfizer
Novartis
Sanofi
Regeneron shares jump on Sanofi share buy plan
Marketwatch
Mon, 02/11/13 - 11:08 am
Sanofi
Regeneron
Sanofi advances after FDA delays rival insulin product
The Fly on the Wall
Mon, 02/11/13 - 11:07 am
FDA
insulin
Novo Nordisk
Sanofi
Tresiba
Lantus
Viehbacher Sees New Sanofi Growing in Diagnostics, Nutrition
Bloomberg
Fri, 02/8/13 - 11:19 am
Chris Viehbacher
Sanofi
diagnostics
Sanofi Misses Earnings But Steps In Right Direction
Seeking Alpha
Thu, 02/7/13 - 10:05 am
Sanofi
earnings
How Big Pharma Gets Bigger, And What Little Pharma Can Do About It
Seeking Alpha
Wed, 02/6/13 - 10:12 am
Big Pharma
Novartis
NovaBay Pharmaceuticals
Sanofi
Roche
Sanofi's New Diabetes Play Moves Forward
Motley Fool
Tue, 02/5/13 - 10:30 am
Sanofi
diabetes
Lyxumia
GLP-1 agonist
Isis: FDA Approval Of Kynamro Promises A Bright Future For Company
Seeking Alpha
Fri, 02/1/13 - 11:40 am
FDA
Kynamro
Isis Pharmaceuticals
Sanofi
Genzyme
Homozygous Familial Hypercholesterolemia
Opko Health: A Potential $8.3 Billion A Year Company In The Making
Seeking Alpha
Thu, 01/31/13 - 10:34 am
OPKO Health
GSK
Merck
Novartis
Sanofi
Tesaro
SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China
Yahoo/MarketWire
Wed, 01/30/13 - 06:11 pm
SciClone Pharmaceuticals
contract
Sanofi
China
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wed, 01/30/13 - 04:16 pm
Eli Lilly
Bristol-Myers Squibb
Novo Nordisk
Pfizer
Sanofi
What's in Regeneron's Pipes?
Motley Fool
Wed, 01/30/13 - 10:42 am
Regeneron
Sanofi
REGN688
Eylea
Sarilumab
Sanofi says FDA starts review of new MS drug Lemtrada; decision due in late 2013
Yahoo/AP
Mon, 01/28/13 - 12:30 pm
FDA
Lemtrada
Sanofi
MS
multiple sclerosis
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 01/28/13 - 12:25 pm
Sanofi
Kynamro
Isis Pharmaceuticals
Regeneron
Eli Lilly
Pfizer
Merck
Statins Beware?
Motley Fool
Mon, 01/28/13 - 12:21 pm
statins
PCSK9 inhibitors
Sanofi
Amgen
Pfizer
Roche
Regeneron

Pages